Jamie Murphy
Comptroller/Controller/Auditor presso SIGILON THERAPEUTICS, INC.
Profilo
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Posizioni attive di Jamie Murphy
Società | Posizione | Inizio |
---|---|---|
SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Precedenti posizioni note di Jamie Murphy
Società | Posizione | Fine |
---|---|---|
LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Formazione di Jamie Murphy
Wake Forest University | Undergraduate Degree |
Northeastern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
SIGILON THERAPEUTICS, INC. | Health Technology |
LARIMAR THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Jamie Murphy